How big is the VVC Market | Growth Insights & Trends 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA9520

Publication Date: Sep 2025

What is the size of VVC Market?

According to 6Wresearch internal database and industry insights, the VVC Market was valued at USD 3.2 Billion in 2024 and is expected to reach USD 6.8 Billion by 2031, growing at a CAGR of 11.3% during the 2025-2031.

The main drivers of this growth are the increasing prevalence of vaginal infections, rising awareness about vaginal health, advancements in diagnostic and therapeutic solutions, and the growing demand for over-the-counter treatments for vaginal health issues like Vaginal Vulvovaginal Candidiasis (VVC).

Growth Factors for VVC Market

Rising prevalence of vaginal infections, particularly among women of reproductive age.
Growing awareness about the importance of vaginal health and prevention of recurrent infections.
Increasing demand for over-the-counter antifungal treatments and probiotics for managing VVC.
Advancements in diagnostics leading to better detection and treatment of VVC.
Rising focus on non-pharmacological treatments, such as probiotics and natural antifungal remedies.

VVC Market Trends

Increasing utilization of antifungal treatments, both oral medications and topical creams, for the management and prevention of recurrent VVC is among the trends currently observed in the VVC market. In addition, there is increased demand for probiotics that are marketed as natural options for maintaining vaginal health and preventing vaginal infections. Virtual or telemedicine and digital health platforms are increasingly being utilized to offer virtual consultations for diagnosis and management of treatment, allowing women to access care from home more easily.

Emerging Developments in the VVC Market

The VVC market is experiencing developments in more targeted therapies, including new antifungal agents or combination therapies that address recurrence. New diagnostic tools are in development as quicker and more accurate means of testing for VVC and its causative agents. There is a growing body of research exploring the role of the vaginal microbiome and its associated benefits for the prevention of infection, leading to the development of microbiome-targeted therapies. Finally, there is growing evidence of interest behind self-care products for women in preventing and managing VVC independently at home.